Your child will be cared for by one of the most accomplished teams of cellular therapy and transplant experts in the world. Our team includes doctors, nurses, social workers, nutritionists, psychologists and more.
Jun 14, 2022
A group of researchers that includes CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.
May 23, 2022
International collaboration aims to ensure more equitable access to transformative personalized cancer therapy.
May 23, 2022
CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.
May 11, 2022
Emily Whitehead, now 17, received life-saving treatment at CHOP, transforming the field of cancer immunotherapy.
May 11, 2022
Whitehead received life-saving treatment at CHOP, under the care of Dr. Stephan Grupp, transforming the field of cancer immunotherapy.
Feb 2, 2022
A new study in Nature has documented the longest persistence of CAR T cell therapy to date.
Jan 4, 2022
Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.
Dec 13, 2021
A cell and gene therapy expert, Grupp discussed progress in clinical care in the 50 years since the legislation was signed.
May 12, 2021
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
Oct 21, 2019
The National Academy of Medicine elects two global leaders in cellular and gene therapy from Children’s Hospital of Philadelphia.